UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:October 20,
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ayala Pharmaceuticals (QX) Charts.
Ayala Pharmaceuticals (QX) (USOTC:ADXS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ayala Pharmaceuticals (QX) Charts.

Advaxis, Inc. News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form DEFM14C - Definitive information statement relating to merger or acquisition
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)
Form PREM14C - Preliminary information statements relating to merger or acquisition
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Monday 12 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K/A - Current report: [Amend]
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)

More Advaxis, Inc. News Articles